Navigating & Assessing Combination with Checkpoint Inhibitors & Other Options

Time: 2:30 pm
day: Day Two

Details:

  • Innate immune stimulating therapies and their contribution to T-cell-based immunotherapies
  • Orchestrating T-cell recruitment and infiltration at the tumor site by targeting the myeloid lineage component of the innate immune system

Speakers: